Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects
Titel:
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects
Auteur:
Gavazzoni, Mara Lombardi, Carlo Mario Vizzardi, Enrico Gorga, Elio Sciatti, Edoardo Rossi, Laura Belotti, Angelo Rossi, Giuseppe Metra, Marco Raddino, Riccardo